From the Dean’s Office

Latest News from the Dean of the Uva School of Medicine

Menu
Featured

SAMHSA – Mental and Substance Use Disorder Practitioner Data

Purpose: The purpose of this program is to provide comprehensive data and analysis on individuals who comprise the prevention and treatment fields to address mental and substance use disorders. The…
Learn More

NIH – Diversity Program Consortium Dissemination and Translation Awards (U01-Clinical Trial Not Allowed)

Purpose: This Funding Opportunity Announcement (FOA) solicits applications from sites not currently part of the Common Fund Enhancing Diversity in the Biomedical Research Workforce initiative, also known as the Diversity Program…
Learn More

NIH – Exploratory Alzheimer’s Disease Research Centers (P20 Clinical Trial Not Allowed)

Purpose: This Funding Opportunity Announcement (FOA) invites applications to establish NIA Exploratory Alzheimer's Disease Centers. NIA's primary goal in offering this P20 funding opportunity is to incentivize innovative ideas and…
Learn More

All Stories

NIH – Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations – RADx-UP Phase II (U01 Clinical Trial Optional)

Purpose: This funding opportunity announcement (FOA) uses an emergency U01 mechanism to support Phase II of the Rapid Acceleration of Diagnostics – Underserved Populations (RADxSM-UP) initiative. These two-year Testing Research…

Wellcome Leap – $55M Delta Tissue Program

Purpose We need a new platform – a ‘tissue time machine’ – that can profile tissue states and predict transitions between states (‘Delta Tissue’ or ‘ΔT’). The platform would provide…

NIH – Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01 Clinical Trial Optional)

Purpose: This Funding Opportunity Announcement (FOA) encourages applications from institutions/organizations proposing original research addressing barriers that limit progress toward effective cell therapies for type 1 diabetes (T1D). The purpose is…

NIH – BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed)

Purpose: This FOA solicits applications for research projects that seek to understand how circuit activity gives rise to mental experience and behavior using innovative, methodologically-integrated approaches. The goal is to…

NIH – Cutting Edge Informatics Tools for Illuminating the Druggable Genome (U01 Clinical Trial Not Allowed)

Purpose: The overarching goal of this funding opportunity announcement (FOA) for the Common Fund program "Illuminating the Druggable Genome" (IDG;https://commonfund.nih.gov/idg/ is to solicit applications to build a set of Cutting Edge…

NIH – Multidisciplinary Treatment Approaches to End the HIV Epidemic (R01 Clinical Trial Optional) and related RFAs

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to utilize implementation science to develop, implement, and evaluate creative, multidisciplinary approaches to healthcare delivery that more effectively engage and…